Banque Cantonale Vaudoise Neogenomics Inc Transaction History

Banque Cantonale Vaudoise

$2.57 Billion
Q3 2025

A detailed history of Banque Cantonale Vaudoise transactions in Neogenomics Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 18,117 shares of NEO stock, worth $187,329. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,117

Previous 19,669 7.89%

Holding current value

$187,329

Previous $143,000 2.8%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$4.84 - $8.81 $7,511 - $13,673	-1,552 Reduced 7.89%	18,117 $139,000
Q2 2025 Aug 11, 2025	SELL	$6.4 - $10.27 $3,737 - $5,997	-584 Reduced 2.88%	19,669 $143,000
Q1 2025 May 08, 2025	BUY	$9.09 - $18.61 $28,969 - $59,310	3,187 Added 18.67%	20,253 $192,000
Q3 2024 Nov 08, 2024	SELL	$13.4 - $17.73 $6,820 - $9,024	-509 Reduced 2.9%	17,066 $252,000
Q2 2024 Jul 31, 2024	BUY	$13.01 - $15.77 $21,245 - $25,752	1,633 Added 10.24%	17,575 $244,000

Q1 2024 Apr 10, 2024	BUY	$14.06 - $16.79 $13,961 - $16,672	993 Added 6.64%	15,942 $251,000
Q4 2023 Feb 07, 2024	SELL	$11.67 - $20.73 $1,832 - $3,254	-157 Reduced 1.04%	14,949 $242,000
Q3 2023 Nov 08, 2023	SELL	$12.15 - $17.85 $18,747 - $27,542	-1,543 Reduced 9.27%	15,106 $186,000
Q2 2023 Aug 09, 2023	BUY	$14.1 - $19.83 $21,206 - $29,824	1,504 Added 9.93%	16,649 $267,000
Q1 2023 Apr 20, 2023	BUY	$9.09 - $19.45 $8,953 - $19,158	985 Added 6.96%	15,145 $264,000
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $1,876 - $3,512	291 Added 2.1%	14,160 $131,000
Q3 2022 Oct 17, 2022	SELL	$7.86 - $12.91 $1,917 - $3,150	-244 Reduced 1.73%	13,869 $119,000
Q2 2022 Aug 02, 2022	SELL	$7.06 - $13.97 $2,308 - $4,568	-327 Reduced 2.26%	14,113 $115,000
Q1 2022 May 09, 2022	BUY	$12.15 - $35.28 $43,217 - $125,490	3,557 Added 32.68%	14,440 $175,000
Q4 2021 Feb 14, 2022	SELL	$30.49 - $48.49 $333,926 - $531,062	-10,952 Reduced 50.16%	10,883 $371,000
Q3 2021 Oct 29, 2021	SELL	$41.66 - $52.52 $70,072 - $88,338	-1,682 Reduced 7.15%	21,835 $1.05 Million
Q2 2021 Aug 11, 2021	SELL	$36.62 - $51.69 $31,639 - $44,660	-864 Reduced 3.54%	23,517 $1.06 Million
Q1 2021 May 11, 2021	SELL	$41.56 - $59.88 $207,841 - $299,459	-5,001 Reduced 17.02%	24,381 $1.18 Million
Q4 2020 Feb 05, 2021	BUY	$36.08 - $56.47 $137,825 - $215,715	3,820 Added 14.94%	29,382 $1.58 Million
Q3 2020 Oct 30, 2020	BUY	$33.26 - $40.48 $10,476 - $12,751	315 Added 1.25%	25,562 $942,000
Q2 2020 Jul 22, 2020	BUY	$24.21 - $31.02 $58,733 - $75,254	2,426 Added 10.63%	25,247 $782,000
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $45,284 - $76,276	-2,209 Reduced 8.83%	22,821 $630,000
Q4 2019 Feb 10, 2020	BUY	$18.96 - $29.84 $474,568 - $746,895	25,030 New	25,030 $732,000

Others Institutions Holding NEO

# of Institutions

291

Shares Held

132M

Call Options Held

1.3M

Put Options Held

395K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.3B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Neogenomics Inc Transaction History